Lowe, M., Qian, D., Switchenko, J., Sullivan, R. J., Hamid, O., Yushak, M. L., Lawson, D. H., Wilson, N. R., Buchwald, Z. (2026). The TIME trial: Phase II randomized controlled trial of time-of-day–specified nivolumab and ipilimumab for advanced melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2677